Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Authors:
- 25 July 2023
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 249, 125997
Abstract
No abstract availableKeywords
Funding Information
- Chengdu University of Traditional Chinese Medicine (030040018)
This publication has 118 references indexed in Scilit:
- Nanobodies: Natural Single-Domain AntibodiesAnnual Review of Biochemistry, 2013
- The safety and side effects of monoclonal antibodiesNature Reviews Drug Discovery, 2010
- Molecular engineering and design of therapeutic antibodiesCurrent Opinion in Immunology, 2008
- Historical Development of Monoclonal Antibody Therapeutics2008
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- HypothesisHypertension, 2003
- Angiotensin-converting enzyme 2 is an essential regulator of heart functionNature, 2002
- Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop librariesMolecular Immunology, 2001
- Naturally occurring antibodies devoid of light chainsNature, 1993